Skip links



Freya has developed GPX-506a-c – fortified antibiotics, cyclosporine and ketotifen eluting contact lenses to provide sustained release resulting in therapeutic concentrations for extended durations, eliminating the peaks and troughs in concentrations from drops, which may cause sub-therapeutic concentration between drop instillations, which can lead to infection proliferation and/or development of resistance

Other Diseases

Vitamin E technology is a Platform Technology Adaptable to any drug of interest for delivery to front and back of eye

Olapatadine release (µg)

Anti-allergy; Superior to J&J Ketotifen lens, which release for a few hours, Anti-allergy Contact Lens